News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Galbraith Kenneth
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2023 |
4
| Galbraith Kenneth (Chair & CEO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 215,000 options to buy
@ $8, valued at
$1.7M
Granted 143,000 restricted stock units
@ $0 |
|
| 01/18/2022 |
4
| Galbraith Kenneth (Chair, President & CEO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 500,000 options to buy
@ $14.97, valued at
$7.5M
|
|
| 01/18/2022 |
3
| Galbraith Kenneth (Chair, President & CEO) has filed a Form 3 on Zymeworks Inc. |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
4
| Galbraith Kenneth (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Sold 13,849 shares
@ $27.11, valued at
$375.4k
Sold 6,924 shares
@ $27.11, valued at
$187.7k
Exercised 13,849 options to buy
@ $16, valued at
$221.6k
Exercised 6,924 options to buy
@ $20.15, valued at
$139.5k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2019 |
4
| Galbraith Kenneth (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 10,000 options to buy
@ $18, valued at
$180k
|
|
| 05/21/2018 |
4
| Galbraith Kenneth (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 10,000 options to buy
@ $21.34, valued at
$213.4k
|
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/18/2013 |
4
| Galbraith Kenneth (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Bought 46,875 shares
@ $16, valued at
$750k
Converted 1,050,652 shares
@ $0
Converted 204,207 shares
@ $0
Converted 19,724,839 convertible preferred
@ $0
Converted 3,833,767 convertible preferred
@ $0
Exercised (in-or-at-the-money) 287,533 options to buy
@ $0 |
|
| 10/11/2013 |
4
| Galbraith Kenneth (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 13,849 options to buy
@ $16, valued at
$221.6k
|
|
| 10/09/2013 |
3
| Galbraith Kenneth (Director) has filed a Form 3 on MACROGENICS INC |
| 01/15/2013 |
3
| Galbraith Kenneth (Director) has filed a Form 3 on Celator Pharmaceuticals Inc |
|
|